Related Experiment Video

Updated: Jun 5, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

[Secondary and tertiary prevention of allergic asthma in children]

F Rancé1, A Deschildre, E Bidat

  • 1TSA 70034, Pôle Médicochirurgical de Pédiatrie, Hôpital des Enfants, 330 Avenue de Grande-Bretagne, 31059 Toulouse Cedex, France. rance.f@chu-toulouse.fr

Revue Des Maladies Respiratoires
|December 18, 2010
PubMed

Insights

Defining asthma phenotypes is key for effective prevention and treatment. Specific immunotherapy shows promise in preventing asthma development and new allergies in children.

Area of Science:

  • Pulmonology
  • Allergology
  • Pediatrics

Context:

  • Asthma is a lung disease linked to allergy in children, where phenotype expression depends on atopic status.
  • Current prevention strategies like allergen avoidance and antihistamines have limited efficacy.
  • Better asthma phenotyping is needed for targeted interventions.

Purpose:

  • To explore secondary and tertiary prevention strategies for allergic asthma in children.
  • To evaluate the effectiveness of allergen avoidance and specific immunotherapy.
  • To define the role of immunotherapy in managing allergic asthma.

Summary:

  • Secondary prevention focuses on preventing asthma onset and new sensitizations, with immunotherapy showing potential.
  • Tertiary prevention aims to reduce symptoms in diagnosed children, requiring environmental management alongside immunotherapy.
  • Allergen avoidance alone is insufficient; immunotherapy, combined with background therapy, is recommended per guidelines.

Impact:

  • Improved understanding of asthma phenotypes can lead to more precise treatment strategies.
  • Specific immunotherapy may prevent asthma progression and new allergic sensitizations.
  • Integrated management approaches, including immunotherapy, can enhance outcomes for children with allergic asthma.

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...